振德医疗：协议转让事项尚需合规性审核 能否最终完成尚存在不确定性

Core Viewpoint - The stock of ZhenDe Medical has experienced abnormal trading fluctuations, with a cumulative closing price deviation exceeding 20% over three consecutive trading days [1] Group 1: Stock Trading and Transfer - The controlling shareholder, Zhejiang ZhenDe, along with its wholly-owned subsidiary, Xuchang Garden, is transferring a total of 13,322,560 unrestricted circulating shares, accounting for 5.00% of the company's total share capital [1] - The shares are being transferred at a price of RMB 26.74 per share, resulting in a total transaction value of RMB 356 million [1] - The transfer is subject to compliance review by the Shanghai Stock Exchange and must complete the share transfer registration with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [1] Group 2: Uncertainties and Conditions - The completion of this transaction is uncertain due to the existence of pledges on the transferred shares, which must be resolved before the transfer can be finalized [1]